Related Experiment Video
Updated: Apr 30, 2026

Osteoclast Derivation from Mouse Bone Marrow
Published on: November 6, 2014
Discoidin domain receptor 2 facilitates prostate cancer bone metastasis via regulating parathyroid hormone-related
Zhang Yan1, Su Jin2, Zhang Wei3
1Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University College of Medicine, Xi'an, PR China.
Abstract:
Prostate cancer frequently metastasizes to the skeleton but the underlying mechanism remains largely undefined. Discoidin domain receptor 2 (DDR2) is a member of receptor tyrosine kinase (RTK) family and is activated by collagen binding. This study aimed to investigate the function and detailed mechanism of DDR2 in prostate cancer bone dissemination. Herein we found that DDR2 was strongly expressed in bone-metastatic prostate cancer cells and tissues compared to that in normal controls. Enhanced expression of constitutively activated DDR2 led to elevation in motility and invasiveness of prostate cancer cells, whereas knockdown of DDR2 through specific shRNA caused a dramatic repression. Knockdown of DDR2 in prostate cancer cells resulted in significant decrease in the proliferation, differentiation and function of osteoblast. Over-expression of DDR2 in prostate cancer cells resulted in notable acceleration of osteoclast differentiation and bone resorption, whereas knockdown of DDR2 exhibited the opposite effects. An intrabone injection bone metastasis animal model demonstrated that DDR2 promoted osteolytic metastasis in vivo. Molecular evidence demonstrated that DDR2 regulated the expression, secretion, and promoter activity of parathyroid hormone-related protein (PTHrP), via modulating Runx2 phosphorylation and transactivity. DDR2 was responsive to TGF-β and involved in TGF-β-mediated osteoclast activation and bone resorption. In addition, DDR2 facilitated prostate cancer cells adhere to type I collagen. This study reveals for the first time that DDR2 plays an essential role in prostate cancer bone metastasis. The mechanism disclosure may provide therapeutic targets for the treatment of prostate cancer.
Insights
Discoidin domain receptor 2 (DDR2) drives prostate cancer bone metastasis by promoting cell invasion and altering bone remodeling. Targeting DDR2 may offer new strategies against skeletal complications in prostate cancer patients.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Prostate cancer commonly metastasizes to bone, causing significant morbidity.
- The molecular mechanisms underlying prostate cancer bone metastasis are not fully understood.
- Discoidin domain receptor 2 (DDR2), a collagen-binding receptor tyrosine kinase (RTK), is implicated in cancer progression.
Purpose of the Study:
- To investigate the role and mechanism of DDR2 in prostate cancer bone metastasis.
- To elucidate how DDR2 influences prostate cancer cell behavior and bone microenvironment interactions.
Main Methods:
- Analysis of DDR2 expression in prostate cancer tissues and cells.
- In vitro studies using prostate cancer cell lines with altered DDR2 expression (overexpression and knockdown via shRNA).
- Assessment of cell motility, invasiveness, proliferation, osteoblast differentiation, and osteoclast differentiation.
- In vivo bone metastasis model using intrabone injection.
- Molecular analyses of parathyroid hormone-related protein (PTHrP) regulation and TGF-β signaling.
Main Results:
- DDR2 expression is significantly elevated in bone-metastatic prostate cancer.
- DDR2 overexpression enhances prostate cancer cell motility and invasiveness.
- DDR2 knockdown inhibits prostate cancer cell proliferation, osteoblast function, and osteoclast differentiation/bone resorption.
- DDR2 promotes osteolytic bone metastasis in vivo.
- DDR2 regulates PTHrP expression and activity via Runx2.
- DDR2 interacts with TGF-β signaling and facilitates cancer cell adhesion to collagen.
Conclusions:
- DDR2 plays a critical role in promoting prostate cancer bone metastasis.
- DDR2 influences both cancer cell aggressiveness and bone microenvironment remodeling.
- Understanding DDR2's mechanism provides potential therapeutic targets for treating prostate cancer bone metastasis.
Related Concept Videos
The Parathyroid Glands
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

